Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 2/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 9/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6797796 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL10417607 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL6797801 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL10824776 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL6807464 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL6807462 | 0.89 | L3MBTL1 (0.40) | L3MBTL1SELPMCHR1 | |
| SCHEMBL10610554 | 0.88 | TLR4 (0.42) | L3MBTL1SELP | |
| SCHEMBL10610859 | 0.88 | TLR4 (0.42) | L3MBTL1SELP | |
| SCHEMBL8434091 | 0.88 | L3MBTL1 (0.37) | L3MBTL1SSTR3SSTR5MCHR1SSTR2 | |
| SCHEMBL10417606 | 0.87 | L3MBTL1 (0.41) | L3MBTL1MEN1KMT2ASELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE36385-E | TREATMENT OF TUMORS, ENHANCING IMMUNITY | ONO PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0288888-B1 | Novel glucopyranose derivatives | ONO PHARMACEUTICAL CO (JP) | 1993-12-08 | — | — | EP | disclosed |
| US-4925929-A | ANTITUMOR AGENTS | ONO PHARMACEUTICAL CO. LTD. (JP) | 1990-05-15 | — | — | US | disclosed |
| EP-0288888-A2 | Novel glucopyranose derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1988-11-02 | — | — | EP | disclosed |
| US-4746742-A | IMMUNOLOGY, ANTI-TUMOR | TOHO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1988-05-24 | — | — | US | disclosed |
| EP-0224260-A2 | Analogs of nonreducing monosaccharide moiety of lipid A | Toho Yakuhin Kogyo Kabushiki Kaisha (JP) | 1987-06-03 | — | — | EP | disclosed |